Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Well, for a company that will run out of cash before the end of this year, sitting near all time lows, struggling to sell shares during the last round of dilution at 2 bucks, and just 78 cents away from starting the delisting process, low institutional interest, all with no significant ground breaking news or cash expected in the near term, yea all those topics are currently very relevant.

As far as the 20, 40, 50, and 100 targets. Yea it must have been on a green day. That always tends to get people excited here.